Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Droperidol for Prevention of Postoperative Delirium in Elderly Patients
NCT05401058Terminated
- Sponsor
- Renji Hospital
- Start
- Nov 2022
- Primary completion
- Dec 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of droperidol in postoperative delirium (POD) (2 arms), sponsored by Renji Hospital. Primary endpoint: Incidence of delirium at 7 days. Started Nov 2022; status: terminated.
02
Drugs
droperidol
03
Conditions
postoperative delirium (POD)
Beyond the preview
Go deeper on NCT05401058.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05401058.